✨ Where in the world has the Golden Hoodie been?
This time: Salt Lake City for #ARVO2025 – one of the largest gatherings of vision researchers. 👁️💡
Mike Hess hit the floor making powerful connections and turning heads (yep, the Hoodie stole the show again 😎).
📸 Catch the highlights here: https://youtube.com/shorts/ZUgNOaWNhHQ
Want individual photos with alt text? Drop a comment and we’ll get them over to you!
More to come…the Golden Hoodie doesn’t stay in one place for long. ✨
Today! Jeff Stern presents "Safety & Tolerability of RPE Stem Cell-derived RPE Implantation in Patients with Dry Age-related #MacularDegeneration: Early Low Dose Clinical Outcomes"
Session Title | Clinical advances in cell & gene therapy
Time | 8:30 - 10:15 AM
Room | Ballroom B
Today @ #ARVO2025: Brigitte Arduini will present "Preclinical safety and efficacy of an adult progenitor cell product, RPESC-RPE-4W, as therapy for dry Age-Related #MacularDegeneration"
Session Info
Title | Stem cell and gene therapy
Time | 3:15 - 5pm (talk @ 3:15pm)
Room | 255E
Drs. Brigitte Arduini and Jeffrey Stern will be presenting preclinical and clinical data, respectively, on our Luxa-sponsored adult stem cell-derived investigational therapy for age-related #MacularDegeneration at the upcoming #ARVO2025 annual meeting!
Announcement | https://zurl.co/jHaZd
Exciting News from Luxa! We’re proud to announce that Dr. Jeffrey Stern, and Dr. Brigitte Arduini will be presenting our latest clinical and preclinical data on Luxa’s adult retinal pigment epithelial stem cell (RPESC) therapy for dry age-related macular degeneration (AMD) at the 2025 ARVO Annual Meeting in Salt Lake City, Utah. The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting is the leading global forum for eye and vision scientists to share cutting-edge research and foster collaboration across disciplines. The 2025 theme highlights how vision research continues to be transformed by emerging technologies and new insights. Presentation Details 🔹 Clinical Advances in Cell and Gene Therapy Title: Safety and Tolerability of RPE Stem Cell-derived RPE (RPESC-RPE) Implantation in Patients with Dry AMD: Early Low Dose Clinical Outcomes Presenter: Dr. Jeffrey Stern Session: Paper Session, Presentation #2701 Date/Time: Tuesday, May 6, 2025 | 9:00–9:15 AM (Mountain) Location: Ballroom B 🔹 Stem Cell and Gene Therapy Title: Preclinical Safety and Efficacy of an Adult Progenitor Cell Product, RPESC-RPE-4W, as Therapy for Dry AMD Presenter: Dr. Brigitte Arduini Session: Paper Session, Presentation #876 Date/Time: Sunday, May 4, 2025 | 3:15–3:30 PM (Mountain) Location: Room 255E We look forward to connecting with fellow researchers and collaborators from around the world. If you’ll be attending ARVO 2025, we’d love to see you there! To explore the full ARVO 2025 program, visit: https://lnkd.in/gnBBk4TM #ARVO2025 #Ophthalmology #DryAMD #CellTherapy #MacularDegeneration #ARVOAnnualMeeting
Blind Institute of Technology
Regenerative Research Fdn/NSCI